A detailed history of Trexquant Investment LP transactions in Chroma Dex Corp. stock. As of the latest transaction made, Trexquant Investment LP holds 442,459 shares of CDXC stock, worth $2.72 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
442,459
Previous 133,887 230.47%
Holding current value
$2.72 Million
Previous $822,000 230.41%
% of portfolio
0.03%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
N/A
308,572 Added 230.47%
442,459 $2.72 Million
Q2 2025

Aug 12, 2025

SELL
$5.42 - $7.08 $411,372 - $537,364
-75,899 Reduced 36.18%
133,887 $822,000
Q1 2025

May 14, 2025

BUY
$5.26 - $8.55 $960,491 - $1.56 Million
182,603 Added 671.75%
209,786 $1.45 Million
Q4 2024

Feb 12, 2025

BUY
$3.25 - $7.72 $88,344 - $209,852
27,183 New
27,183 $144,000
Q1 2018

May 03, 2018

SELL
$4.05 - $6.46 $177,179 - $282,612
-43,748 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$3.88 - $6.96 $169,742 - $304,486
43,748
43,748 $257,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $420M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.